Revascularization clinical trials

Explore recruiting revascularization clinical trials.

Recruiting revascularization studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Revascularization trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

Latvia, Italy, Estonia, Czechia, Finland, Netherlands +16 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

EVOLVE-MI: A Pragmatic Randomized Multicenter Trial of EVOLocumab Administered Very Early to Reduce the Risk of Cardiovascular Events in Patients Hospitalized With Acute Myocardial Infarction

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

"MetCool ACS"- Metformin "Cooling" Effect on metformin-naive Patients Treated with PCI because of Acute Coronary Syndrome

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

RIISC Evaluation of low dose colchicine in prevention of ischemic stroke in patients with stroke due to atherosclerosis. Reducing inflammation in ischemic stroke with colchicine (riisc),

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase II: 68Ga-NODAGA-E[c(RGDyK)]2 Angiogenese PET for imaging angiogenesis in ischemic heart disease

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA)

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

Revascularization trials by city

Revascularization in Toronto Revascularization in Vancouver Revascularization in Montreal Revascularization in Calgary Revascularization in Edmonton Revascularization in Ottawa Revascularization in Winnipeg Revascularization in Quebec City Revascularization in Hamilton Revascularization in Kitchener Revascularization in London Revascularization in Halifax Revascularization in New York Revascularization in Los Angeles Revascularization in Chicago Revascularization in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease